EGFR family signaling and its association with breast cancer development and resistance to chemotherapy (Review)

  • Authors:
    • Patrick M. Navolanic
    • Linda S. Steelman
    • James A. McCubrey
  • View Affiliations

  • Published online on: February 1, 2003     https://doi.org/10.3892/ijo.22.2.237
  • Pages: 237-252
Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )


Abstract

Epidermal growth factor (EGF) receptors (EGFRs) and signaling pathways activated by these receptors have been associated with development of breast cancer as well as its resistance to treatment with cytotoxic drugs. This review describes the current understanding of EGFRs and their downstream signaling pathways. Emphasis is placed upon Raf/MEK/ERK and PI3K/PDK1/Akt signaling pathways and their relationship to regulation of apoptosis and cell cycle progression. Also discussed is the relationship between these signaling pathways and response of breast cancer to chemotherapeutic treatment. An appreciation of how these signaling pathways relate to development of breast cancer and its response to chemotherapy may lead to improved prevention, diagnosis, and treatment of this disease.

Related Articles

Journal Cover

February 2003
Volume 22 Issue 2

Print ISSN: 1019-6439
Online ISSN:1791-2423

Sign up for eToc alerts

Recommend to Library

Copy and paste a formatted citation
x
Spandidos Publications style
Navolanic PM, Steelman LS and McCubrey JA: EGFR family signaling and its association with breast cancer development and resistance to chemotherapy (Review). Int J Oncol 22: 237-252, 2003
APA
Navolanic, P.M., Steelman, L.S., & McCubrey, J.A. (2003). EGFR family signaling and its association with breast cancer development and resistance to chemotherapy (Review). International Journal of Oncology, 22, 237-252. https://doi.org/10.3892/ijo.22.2.237
MLA
Navolanic, P. M., Steelman, L. S., McCubrey, J. A."EGFR family signaling and its association with breast cancer development and resistance to chemotherapy (Review)". International Journal of Oncology 22.2 (2003): 237-252.
Chicago
Navolanic, P. M., Steelman, L. S., McCubrey, J. A."EGFR family signaling and its association with breast cancer development and resistance to chemotherapy (Review)". International Journal of Oncology 22, no. 2 (2003): 237-252. https://doi.org/10.3892/ijo.22.2.237